# The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

> **NCT01267305** · NA · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 362 (actual)

## Conditions studied

- Lung Neoplasms
- Esophageal Neoplasms
- Venous Thromboembolism

## Interventions

- **DRUG:** Fondaparinux
- **DRUG:** Nadroparin Calcium
- **DRUG:** Nadroparin Calcium

## Key facts

- **NCT ID:** NCT01267305
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-04
- **Final completion:** 2013-08
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2014-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01267305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01267305, "The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01267305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*